Partnership
microport-medbot x aws
MicroPort MedBot uses AWS for medical robot data management and surgical analytics
technology · Active · operating
Machine-readable surfaces
- Markdown mirror: /partnerships/microport-medbot-x-aws.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/partnerships/microport-medbot-x-aws
- Revision history: /partnerships/microport-medbot-x-aws/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
5ee3f705-379e-4ebf-9ca4-3502ca7d0f34- Type
- technology
- Status
- Activeoperating
Who’s involved
Shanghai MicroPort MedBot (Group) Co., Ltd. (HKEX: 02252) is a surgical robotics company spun out of [MicroPort Scientific](/companies/microport-scientific) in 2015. Its flagship [Toumai](/models/toumai) laparoscopic surgical robot has received regulatory approval in over 60 countries and achieved 100+ commercial orders, making it the leading Chinese-developed surgical robot globally. The company covers five surgical robotics subsectors: endoscopy, orthopedics, vascular intervention, natural orifice surgery, and percutaneous puncture.
[Amazon web services](/companies/amazon-web-services) (AWS) is the cloud computing division of Amazon, providing on-demand cloud platforms including compute, storage, database, and AI/ML services. AWS powers infrastructure for autonomous vehicle simulation, robotics development, and AI training workloads.
Most-frequent partners
Related partnerships
Other partnerships of MicroPort MedBot
- technology—operating
Other partnerships of AWS
- technology—operating
- technology—operating
- technology—operating
- technology—operating
- technology—just announced
Recent partnerships of the same kind
- technology—operating
- technology—operating
- technology—just announced
- loram x One Big CircleLoram + One Big Circletechnology—operating
- iron-mountain-data-centers x Check Point SoftwareIron Mountain Data Centers + Check Point Softwaretechnology—operating
- technology—operating
Sources (1)
Deploy Watch
Track this partnership.
We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.